NAT (National AIDS Trust) welcomes Dame Carol Black’s Review of Drugs. The report highlights that the Government’s current drug strategy is failing and with drug deaths at a record high more needs to be done to implement radical and innovative solutions to prevent further avoidable deaths.

Natasha Dhumma, Head of Policy and Campaigns at NAT (National AIDS Trust), said:

Deborah Jack, Chief Executive of NAT (National AIDS Trust), comments:

'NAT welcome the exciting news that taking antiretroviral drugs (drugs that help treat HIV) before being exposed to HIV may prevent HIV infection. This is known as pre-exposure prophylaxis, or PrEP, and could become a significant weapon in the fight against HIV.